Heart transplanation: The end of the beginning

American Journal of Transplantation

Volumn 8, Issue 9, 2008, Pages 1767-1768

  Yacoub, M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; EDITORIAL; HEART FAILURE; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEOPLASM; ORGAN DONOR; PRIORITY JOURNAL; SURVIVAL; HEART DISEASE; HUMAN; IMMUNOLOGY; MORTALITY; NOTE; SURVIVOR;

HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; SURVIVAL ANALYSIS; SURVIVORS;

EID: 49649088185     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02366.x     Document Type: Editorial

References (11)

1. Deuse T, Haddad F, Pham M et al. 20-year survivors of heart transplantation at Stanford University. Am J Transpl 2008 In Press.
2. Weiss MJ, Madsen JC, Rosengard BR, Allan JS. Mechanisms of chronic rejection in cardiothoracic transplantation. Front Biosci 2008 13 : 2980 2988. Review.
3. Results of the Prospective multicenter European trial to evaluate the safety and performance of the Organ Care System for Heart Transplants (PROTECT) - Presented at the ISHLT Meeting, San Francisco 2005.
4. Yacoub MH, Suzuki K, Rosenthal N. The future of regenerative therapy in patients with chronic heart failure. Nature Clin Pract Cardiovasc Med 2006 3 : S133 S135.
5. Densem CG, Hutchison IV, Cooper A, Yonan N, Brooks NH. Poltymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transpl 2000 19 : 551 556.
6. Cunningham DA, Crisp SJ, Barbir M, Lazem F, Dunn MJ, Yacoub MH. Donor ACE gene polymorphism: A genetic risk factor for accelerated coronary sclerosis following cardiac transplantation. Eur Heart J 1998 19 : 319 325.
7. Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 1999 83 : 984 986.
8. Yacoub MH, Yuen AH, Kalsi KK et al. C34 T AMP deaminase 1 gene mutation protects cardiac function in donors. Transplantation 2004 77 : 1621 1623.
9. vanGelder T, Hesselink DA, van Hest RM, Mathot RA, van Schaik R. Pharamcogenetics in immunosuppressive therapy: The best thing since TDM? Ther Drug Monit 2004 26 : 343 346.
10. Taegtmeyer AB, Barton PJ, Yacoub MH. Genetic association studies: Personalized medicine in cardiac transplantation. Nature Clin Pract Cardiovasc Med 2006 3 : 58 59.
11. Billingham RE, Brent L, Medawar PM. Actively acquired tolerance of foreign cells. Nature 1953 172 : 603 606.